tiprankstipranks
Trending News
More News >
Hengan International Group Co (HK:1044)
:1044
Advertisement

Hengan International Group Co (1044) AI Stock Analysis

Compare
4 Followers

Top Page

HK:1044

Hengan International Group Co

(OTC:1044)

Rating:72Outperform
Price Target:
HK$24.50
▲(0.25% Upside)
The overall stock score reflects strong valuation metrics, with a low P/E ratio and high dividend yield, which are major strengths. Technical indicators show positive momentum, supporting a favorable outlook. However, financial performance is hampered by challenges in revenue growth and cash flow generation, which need to be addressed for sustained improvement.

Hengan International Group Co (1044) vs. iShares MSCI Hong Kong ETF (EWH)

Hengan International Group Co Business Overview & Revenue Model

Company DescriptionHengan International Group Company Limited, an investment holding company, manufactures, distributes, and sells personal hygiene products in the People's Republic of China and internationally. The company offers pocket handkerchiefs, box and soft tissue papers, kitchen towels/papers, toilet rolls, first-aid products, enema, garbage and food bags, preservation papers, table cloths and swabbers, sanitary napkins, pantiliners, overnight pants, wet tissues, maternal and child care products, adult and baby diapers, and cleansing products. It is also involved in the trading of various products for ladies, pregnant women, infants, and kids, as well as disposable fiber-based products; and engages in the ecommerce business. In addition, the company manufactures and distributes heat and power; and manufactures, distributes, and sells gas, protective equipment, medical instrument, skin care products, antiseptics, and household products. Hengan International Group Company Limited was founded in 1985 and is headquartered in Jinjiang, the People's Republic of China.
How the Company Makes MoneyHengan International Group Co. makes money primarily through the sale of its personal hygiene products across various segments. The company's revenue streams include sanitary napkins, which cater to the female hygiene market, and disposable diapers, targeting infants and toddlers. The adult incontinence products serve an aging population, while the tissue paper segment covers household and personal tissue products. Hengan leverages its extensive distribution network and strong brand recognition to maintain its market presence. Additionally, strategic partnerships and investments in research and development contribute to product innovation, helping the company to sustain and grow its revenue in a competitive market.

Hengan International Group Co Financial Statement Overview

Summary
Hengan International Group Co shows solid profitability and a strong balance sheet with reduced leverage. However, revenue growth and free cash flow generation have faced headwinds, impacting overall performance. The company's ability to maintain profitability margins amidst revenue pressures and its strong equity position remain key strengths. Continued focus on improving cash flow and revenue growth will be crucial for future performance.
Income Statement
65
Positive
The company's gross profit margin for 2024 was approximately 32.30%, which shows a slight decline from 2023's 33.71%. The net profit margin also dropped to 10.14% from 11.78% the previous year. Revenue decreased by 4.63% in 2024, indicating challenges in maintaining growth. However, EBIT and EBITDA margins were relatively stable at 14.79% and 19.56% respectively, though slightly lower than 2023. The overall income statement reflects consistent profitability but challenges in revenue growth.
Balance Sheet
78
Positive
The debt-to-equity ratio improved to 0.63 from 0.70, indicating reduced leverage. The return on equity (ROE) was 10.99% in 2024, down from 13.73% in 2023, due to lower net income. The equity ratio stood at 52.55%, an improvement from 50.70%, showcasing strong equity financing. Overall, the balance sheet is robust, with decreasing debt levels and solid equity ratios, though ROE has been pressured by declining net income.
Cash Flow
60
Neutral
The free cash flow decreased by 35.43% from 2023 to 2024, reflecting lower cash generation. The operating cash flow to net income ratio was 1.34, indicating strong cash generation relative to net income. However, this was a decrease from 1.38 in 2023. The free cash flow to net income ratio was 0.66, down from 0.84 in 2023. The cash flow statement suggests challenges in generating free cash flow despite strong operating cash flow.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.67B23.77B22.62B20.79B22.37B
Gross Profit7.32B8.01B7.69B7.77B9.46B
EBITDA4.43B5.14B4.12B4.55B6.02B
Net Income2.30B2.80B1.93B3.27B4.59B
Balance Sheet
Total Assets39.80B40.22B42.34B42.29B44.44B
Cash, Cash Equivalents and Short-Term Investments14.32B18.22B18.70B18.26B20.60B
Total Debt13.11B14.27B17.07B18.26B20.86B
Total Liabilities18.66B19.59B22.56B23.01B24.78B
Stockholders Equity20.92B20.40B19.52B19.04B19.41B
Cash Flow
Free Cash Flow1.52B2.35B2.57B3.82B4.28B
Operating Cash Flow3.07B3.88B3.81B4.60B5.04B
Investing Cash Flow-110.26M3.58B-6.07B2.68B1.56B
Financing Cash Flow-3.59B-5.55B-4.14B-6.49B-3.93B

Hengan International Group Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.44
Price Trends
50DMA
22.79
Positive
100DMA
21.93
Positive
200DMA
21.69
Positive
Market Momentum
MACD
0.27
Positive
RSI
68.74
Neutral
STOCH
68.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1044, the sentiment is Positive. The current price of 24.44 is above the 20-day moving average (MA) of 23.55, above the 50-day MA of 22.79, and above the 200-day MA of 21.69, indicating a bullish trend. The MACD of 0.27 indicates Positive momentum. The RSI at 68.74 is Neutral, neither overbought nor oversold. The STOCH value of 68.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1044.

Hengan International Group Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
HK$36.97B42.1037.28%1.85%59.83%68.29%
74
Outperform
€3.51B15.906.78%5.18%9.45%12.30%
72
Outperform
HK$28.40B11.1911.12%6.23%-6.53%-18.43%
66
Neutral
HK$418.03M7.6012.01%25.55%14.47%
61
Neutral
HK$761.46M11.878.96%30.72%-35.61%
54
Neutral
C$5.27B4.16-2.52%3.52%18.95%8.48%
48
Neutral
HK$21.28B-7.87%2.67%16.82%-348.71%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1044
Hengan International Group Co
24.44
0.72
3.05%
HK:6993
Blue Moon Group Holdings Ltd.
3.75
1.99
113.07%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.47
-0.27
-36.49%
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
89.60
56.15
167.86%
HK:2023
China Ludao Technology Co. Ltd.
0.86
0.02
2.38%
HK:6601
Cheerwin Group Limited
2.56
0.87
51.84%

Hengan International Group Co Corporate Events

Hengan International Group Co Issues First Tranche of Commercial Papers
May 30, 2025

Hengan International Group Co has successfully issued the first tranche of its super short-term commercial papers, raising RMB1.0 billion with a coupon rate of 1.69% per annum. The proceeds will be used to supplement working capital and repay bank loans, enhancing the company’s financial stability and operational efficiency.

The most recent analyst rating on (HK:1044) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.

Hengan International Group Co Successfully Passes All AGM Resolutions
May 20, 2025

Hengan International Group Co announced that all resolutions proposed at their Annual General Meeting (AGM) held on May 20, 2025, were passed by shareholders. Key resolutions included the approval of audited accounts, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share repurchase and issuance. The successful passing of these resolutions indicates strong shareholder support and positions the company for continued operational stability and strategic growth.

The most recent analyst rating on (HK:1044) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025